Pfizer, Merck to Evaluate Novel Anti-Cancer Combination Regimen

News   Aug 27, 2014

 
Pfizer, Merck to Evaluate Novel Anti-Cancer Combination Regimen
 
 
 
FURTHER INFORMATION
 

This content appears on:

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT